English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The great advances which have been made in recent years in the treatment of gonorrhea infections would appear to have provided the medical profession with adequate therapeutic agents for this disease. The numerous advantages of penicillin treatment have resulted in its replacing the sulfonamide drugs, except in selected cases (1). Even the disadvantages of parenteral injections of penicillin have been avoided by a number of workers who have administered the antibiotic by mouth (1). Indeed, Campbell, Dougherty and Curtis reported on the oral use of penicillin in the prophylaxis of gonorrhea at an earlier session of this Symposium (2). Despite the fact that penicillin has many attributes of an ideal drug for the treatment of gonorrhea, it has one distinct drawback, i.e., its suppressive effect on a coexisting syphilitic infection. This problem of the possible masking of syphilis by treating acute gonorrhea patients with-amounts of penicillin which are adequate for the bacterial infection but inadequate for the spirochetal infection is of tremendous importance (1, 3). Therefore, the search must continue for a drug with the activity of penicillin against the gonococcus but without its marked anti-spirochetal action. This report is a progress note which presents certain preliminary data suggesting that chloramphenicol, or Chloromycetin,2 approaches penicillin in its efficacy in the treatment of acute gonorrheal urethritis in the male and that this new drug is distinctly less spirocheticidal than penicillin.

PRELIMINARY REPORT ON THE USE OF CHLORAMPHENICOL (CHLOROMYCETIN) IN THE TREATMENT OF ACUTE GONORRHEAL URETHRITIS 1